Barclays Maintains Underweight on Dentsply Sirona, Raises Price Target to $11

Benzinga · 3d ago
Barclays analyst Glen Santangelo maintains Dentsply Sirona (NASDAQ:XRAY) with a Underweight and raises the price target from $9 to $11.